AlphaYouEJ
Insider selling
Edward J Dulac III sold $91K of Intellia Therapeutics, Inc. (NTLA) stock
Edward J Dulac III, EVP, Chief Financial Officer of Intellia Therapeutics, Inc. (NTLA), sold 8,111 shares of NTLA stock worth $91K, per an SEC Form 4 filed Jul 24, 2026.
It was an open-market sale.
The trade happened on Jul 22, 2026, 2 days before it was made public.
NTLA has moved +9.8% since the trade date, from $11.13 to $12.22 (Sep 21, 2026 close).
- Traded
- Jul 22, 2026
- Disclosed
- Jul 24, 2026
- Filing delay
- 2 days
- Price since
- +9.8%
- Role
- EVP, Chief Financial Officer
- Source
- SEC Form 4
More NTLA insider and Congress trades
From a public SEC Form 4, linked above. Not investment advice, and not a recommendation to buy or sell.